Estrogens plus raloxifene on endometrial safety and menopausal symptoms—semisystematic review

@article{Carneiro2012EstrogensPR,
  title={Estrogens plus raloxifene on endometrial safety and menopausal symptoms—semisystematic review},
  author={Andrea L{\'u}cia Bastos Carneiro and Rita de C{\'a}ssia de Maio Dardes and M. Haidar},
  journal={Menopause: The Journal of The North American Menopause Society},
  year={2012},
  volume={19},
  pages={830–834}
}
Objective The aim of this study was to summarize the evidence of endometrial safety and quality of life assessment in postmenopausal women taking raloxifene (RLX) + estrogens (E). Methods Clinical studies reporting RLX + E were identified using Medline and LILACS and through reviewing reference lists of highly significant publications. Articles published in Portuguese, Spanish, and English from the past 10 years were considered. Results Six corresponding clinical trials were identified… Expand
4 Citations

References

SHOWING 1-10 OF 18 REFERENCES
The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety
  • 58
  • Highly Influential
Novel agents to modulate oestrogen action.
  • 22
  • PDF
Effects of raloxifene after tamoxifen on breast and endometrial tumor growth in athymic mice.
  • 63
  • PDF
...
1
2
...